von Eitzen U, Meier-Tackmann D, Agarwal D P, Goedde H W
Institute of Human Genetics, University of Hamburg, Germany.
Cancer Lett. 1994 Jan 15;76(1):45-9. doi: 10.1016/0304-3835(94)90132-5.
In in vitro studies, no turnover of aldophosphamide and mafosfamide was observed with the tumor-specific aldehyde dehydrogenase 3 isozyme (ALDH3) isolated from human stomach mucosa as well as from lung (A549) and pharynx (UMSCC2) carcinoma cell lines. Only the human liver cytosolic ALDH preparation (ALDH1) showed any significant oxidation of aldophosphamide and mafosfamide.